Abstract：
BACKGROUND: Literature on advanced practice providers (APPs) prescribing chemotherapy independently, without physician cosignature, is limited.
OBJECTIVE: This project assessed safety and provider satisfaction for an existing independent APP chemotherapy prescribing privilege at a National Cancer Institute-designated comprehensive cancer center.
METHODS: Rate of Reporting to Improve Safety and Quality events associated with APPs with independent chemotherapy prescribing privileges was compared to that of physicians during a three-year period. Satisfaction of APPs with independent chemotherapy prescribing privileges was evaluated.
RESULTS: The odds of a reported event were higher for physicians than for APPs. APP survey responses were positive for readiness, confidence, and satisfaction with independent chemotherapy prescribing privilege.
OBJECTIVE: This project assessed safety and provider satisfaction for an existing independent APP chemotherapy prescribing privilege at a National Cancer Institute-designated comprehensive cancer center.
METHODS: Rate of Reporting to Improve Safety and Quality events associated with APPs with independent chemotherapy prescribing privileges was compared to that of physicians during a three-year period. Satisfaction of APPs with independent chemotherapy prescribing privileges was evaluated.
RESULTS: The odds of a reported event were higher for physicians than for APPs. APP survey responses were positive for readiness, confidence, and satisfaction with independent chemotherapy prescribing privilege.
摘要：
背景：关于高级实践提供者（APP）独立开化疗处方的文献，没有医生共同签名，是有限的。
目的：该项目评估了美国国家癌症研究所指定的综合癌症中心现有的独立APP化疗处方特权的安全性和提供者满意度。
方法：将与独立化疗处方权限的APP相关的提高安全性和质量事件的报告率与医生在三年期间的报告率进行比较。评估了APP对独立化疗处方特权的满意度。
结果：医生报告事件的几率高于APP。APP调查对准备情况的反应是积极的，信心,以及对独立化疗处方特权的满意度。
目的：该项目评估了美国国家癌症研究所指定的综合癌症中心现有的独立APP化疗处方特权的安全性和提供者满意度。
方法：将与独立化疗处方权限的APP相关的提高安全性和质量事件的报告率与医生在三年期间的报告率进行比较。评估了APP对独立化疗处方特权的满意度。
结果：医生报告事件的几率高于APP。APP调查对准备情况的反应是积极的，信心,以及对独立化疗处方特权的满意度。
